Kaufmann Gunnar F. is Chief Scientific Officer of Oncternal Therapeutics Inc.
Person profile
Roles
Oncternal Therapeutics
Chief Scientific Officer
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Oncternal Therapeutics, Inc.
14 Jun 23
4
Oncternal Therapeutics, Inc.
23 Feb 23
4
Oncternal Therapeutics, Inc.
5 Jan 23
4
Oncternal Therapeutics, Inc.
1 Aug 22
4
Oncternal Therapeutics, Inc.
24 Jan 22
4
Oncternal Therapeutics, Inc.
5 Jan 22
4
Oncternal Therapeutics, Inc.
16 Feb 21
4/A
Oncternal Therapeutics, Inc.
31 Jul 20
4/A
Oncternal Therapeutics, Inc.
31 Jul 20
4
Oncternal Therapeutics, Inc.
18 Mar 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Jun 23 | ONCT Oncternal Therapeutics | Common Stock | Buy | Acquire P | No | No | 0.3597 | 3,000 | 1.08 k | 94,726 |
12 Jun 23 | ONCT Oncternal Therapeutics | Common Stock | Buy | Acquire P | No | No | 0.3498 | 25,000 | 8.75 k | 91,726 |
21 Feb 23 | ONCT Oncternal Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 210,000 | 201.60 k | 210,000 |